Our Products

High-quality pharmaceutical intermediates and materials

Chemintra Life Science delivers a comprehensive range of high-quality pharmaceutical intermediates, key starting materials, and specialty chemicals designed to meet the demanding requirements of the pharmaceutical, biotechnology, and life sciences industries.

Our products are manufactured under stringent quality control standards, ensuring consistent purity, reliability, and performance for your research, development, and manufacturing needs.

Product Categories

API Intermediates

Advanced intermediates for active pharmaceutical ingredient synthesis, designed to streamline your manufacturing process.

Building Blocks

Essential chemical building blocks for drug discovery, medicinal chemistry, and pharmaceutical research applications.

Chiral Compounds

High-purity chiral compounds and intermediates with excellent enantiomeric excess for stereoselective synthesis.

Reference Standards

Certified reference materials with detailed analytical documentation for method development and quality control.

Heterocyclic Compounds

Diverse heterocyclic scaffolds for medicinal chemistry and drug discovery programs, including novel structures.

Custom Synthesis

Tailored chemical synthesis services to create compounds according to your specific requirements and specifications.

Featured API Intermediates

PRODUCT NAME	CAS NO	END USE	Status
4-(Methylamino)-3-nitrobenzoic Acid	41263-74-5	Dabigatran Etexilate Mesylate	Commercial
Ethyl 3-(Pyridin-2yl amino) Propionate	103041-38-9	Dabigatran Etexilate Mesylate	Commercial
Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido) propanoate	429659-01-8	Dabigatran Etexilate Mesylate	Commercial
Ethyl 3-[3-Amino-4-(methylamino)-N-2-pyridyl) benzamido]propionate	212322-56-0	Dabigatran Etexilate Mesylate	Commercial
Ethyl 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido) propanoate	1307233-94-8	Dabigatran Etexilate Mesylate	Commercial
Hexyl ((4-Aminophenyl)(imino)methyl)carbamate hydrochloride	1307233-93-7	Dabigatran Etexilate Mesylate	Commercial
Hexyl ((4-Aminophenyl)(imino)methyl)carbamate hydrochloride	1307233-93-7	Dabigatran Etexilate Mesylate	Commercial
2-Propyl-1H-imidazole-4,5-dicarboxylic Acid	58954-23-7	Olmesartan	Commercial
2-Chloro-1,3-bis(dimethylamino)trimethium hexafluorophosphate	249561-98-6	Etoricoxib	Commercial
1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone	221615-75-4	Etoricoxib	Commercial
Tert-butyl 4-(6-nitropyridin-3yl)piperazine-1-carboxylate	571189-16-7	Palbociclib	Commercial
Tert-butyl 4-(6-aminopyridin-3yl)piperazine-1-carboxylate	571188-59-5	Palbociclib	Commercial
tert-Butyl piperazine-1-carboxylate (1-Boc-piperazine)	57260-71-6	Multiple products	Commercial
3-Aminopyridine	462-08-8	Multiple products	Commercial
5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1H-tetrazole	124750-51-2	Olmesartan	Under development
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine	152460-10-1	Imatinib	Under development
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride	06261-49-8	Imatinib	Under development
Lenacapavir intermediates	-NA-	Lenacapavir	Under development